DMKJ
OBIO icon

David M. Knott Jr’s Orchestra BioMed OBIO Stock Holding History

David M. Knott Jr’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Buy
253,651
+3,651
+1% +$15.5K 0.64% 32
2025
Q4 		$1.04M Buy
250,000
+55,000
+28% +$222K 0.48% 34
2025
Q3 		$484K Buy
195,000
+95,000
+95% +$262K 0.2% 54
2025
Q2 		$268K Buy
+100,000
New +$292K 0.12% 53

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

David M. Knott Jr's OBIO Position: Q1 2026 in Review

David M. Knott Jr increased its Orchestra BioMed (OBIO) stake by 1.5% in Q1 2026, buying an estimated $15.5K and bringing the position to 253,651 shares worth $1.08M. The position accounts for 0.64% of the portfolio, ranked #32.

David M. Knott Jr first reported a position in OBIO in Q2 2025 and has held it in 4 quarters since. 65 funds tracked by Wall St. Rank hold OBIO as of Q1 2026.

  • David M. Knott Jr held 253,651 shares of Orchestra BioMed worth $1.08M as of Q1 2026.
  • David M. Knott Jr bought 3,651 Orchestra BioMed shares in Q1 2026, an estimated $15.5K.
  • Orchestra BioMed made up 0.64% of David M. Knott Jr's portfolio in Q1 2026, its #32 holding.
  • David M. Knott Jr first reported a position in Orchestra BioMed in Q2 2025 and has held it in 4 quarters since.
  • 65 funds tracked by Wall St. Rank held Orchestra BioMed as of Q1 2026.

Based on David M. Knott Jr's 13F filing for Q1 2026, filed 14 May 2026.